Financials • Specialty Insurers
$28.81 ▼ -0.67
(-2.27%)
MKT CAP: $3.98B • VOL: 772.9K
52W L $15 52W H $35
ROARABLE / RQD
C • 64/100
PIOTROSKI
7 / 9
NP // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $159.6M | $119.3M | $84.9M |
| YoY Revenue Growth % | +33.7% | +40.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $71.0M | $68.4M | $45.4M |
| Operating Margin % | 44.5% | 57.4% | 53.5% |
| Net Income (GAAP) | $37.4M | $34.6M | $17.9M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $51.7M | $49.9M | $18.6M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $51.7M | $49.9M | $18.6M |
| FCF Margin % | 32.4% | 41.8% | 22.0% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $8.0M | $7.1M | — |
| Total Debt (Short + Long Term) | $0 | $125.1M | — |
| Total Stockholders' Equity | -$227.5M | -$366.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NP.